2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
生物活性
Description
In Vivo
In Vitro
化合物的使用
Kinase Assay
Cell Assay
Animal Administration
参考文献
Description of Ataluren: Ataluren (PTC124) is an investigational new drug designed to enable the Formation of a functioning protein in patients with genetic disorders due to a nonsense mutation. A nonsense mutation is an alteration in the genetic code that prematurely halts the synthesis of an essential protein. Ataluren is currently being investigated For use in patients with nonsense mutation Duchenne/Becker muscular dystrophy (nmDBMD) and cystic fibrosis (nmCF) (source: http://www.ptcbio.com/ataluren).
For the detailed information about the solubility of PTC124 (Ataluren) in water, the solubility of PTC124 (Ataluren) in DMSO, the solubility of PTC124 (Ataluren) in PBS buffer, the animal experiment（test） of PTC124 (Ataluren),the in vivo,in vitro and clinical trial test of PTC124 (Ataluren),the cell experiment（test） of PTC124 (Ataluren),the IC50, EC50 and Affinity of PTC124 (Ataluren), please contact DC Chemicals.
